TL1A antibodies: a new inflammatory disease market
As late-stage trials accumulate and candidates get closer to market, find out about TL1A, a new class in inflammatory diseases. The post TL1A antibodies: a new inflammatory disease market appeared first on Labiotech.eu . © Labiotech UG and Labiotech.eu. Unauthorized use and/or duplication of this material without express and written permission from this site’s author and/or owner is strictly…
We haven't written up this one. Labiotech has the full story — the link below goes straight to it.